Induction of antigen-specific immune tolerance has emerged as the next frontier in treating
autoimmune disorders, including atherosclerosis and graft-vs-host reactions during …

Background At present, the role of autologous cells as antigen carriers inducing immune
tolerance is appreciated. Accordingly, intravenous administration of haptenated syngeneic …

Abstract Type 1 diabetes (T1D) is a chronic metabolic disease caused by the autoimmune
destruction of insulin‐producing β‐cells. Ever since the 1920s, the fate of patients suffering …

A robust regimen for inducing allogeneic transplantation tolerance involves pre-emptive
recipient treatment with donor splenocytes (SP) rendered apoptotic by 1-ethyl-3-(3 …

Increasing prevalence of allergic and autoimmune diseases urges clinicians and
researchers to search for new and efficient treatments. Strategies that activate antigen …

The development of biomaterial-based therapeutics to induce immune tolerance holds great
promise for the treatment of autoimmune diseases, allergy, and graft rejection in …

ABSTRACT Introduction Multiple Sclerosis (MS), as an autoimmune disease, has
complicated immunopathology, which makes its management relevant to various factors …

Nanomedicine approaches have the potential to transform the battle against parasitic worm
(helminth) infections, a major global health scourge from which billions are currently …

Nanomaterials are playing an advancing critical role in the prevention, diagnosis, and
treatment of today's human problems. By engineering with multi-active probes including …

LILRB4, a myeloid inhibitory receptor belonging to the family of leukocyte immunoglobulin-
like receptors (LILRs/LIRs), plays a pivotal role in the regulation of immune tolerance …